CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
JIANGSU EXPRESS (00177) issued the 2026 third, fourth, fifth, and sixth tranche of ultra-short-term commercial papers.
Shanghai Pharmaceuticals Holding (02607): The sustained-release tablets of sitagliptin and metformin from Changzhou Pharmaceutical Factory have been approved for production.
On February 4th, TI CLOUD (02167) spent HKD 55,300 to repurchase 13,800 shares.
JIANGSU EXPRESS (00177) issued the 2026 third, fourth, fifth, and sixth tranche of ultra-short-term commercial papers.
Shanghai Pharmaceuticals Holding (02607): The sustained-release tablets of sitagliptin and metformin from Changzhou Pharmaceutical Factory have been approved for production.
On February 4th, TI CLOUD (02167) spent HKD 55,300 to repurchase 13,800 shares.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
